Founded in 2018, Mestastop Solutions operates in Health Tech industry. Initially focused on tackling metastasis, the company utilises proprietary platforms to identify and develop novel therapeutic ta...
Funding stage:
Seed
Last funding:
18/10/2023
Total funding:
$714.42K+
Revenue:
Investors
Employee count:
23
Last 90d
23
Last 90d
Web traffic:
1.05K
1.05K
Last 30d
Last 30d
Mestastop Solutions: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders30
Latest Filing Date14 May 2024- Funding Events21
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Mestastop Solutions
As of 15 May 2024, Mestastop Solutions's equity is held by 28 shareholders, with the top three being Arnab Roy Chowdhury, Debabani Roy Chowdhury, and Ajith Kamath.
Arnab Roy Chowdhury holds the largest stake in Mestastop Solutions at 30.0% as of 15 May 2024.
As of 15 May 2024, founders collectively hold 58.4% equity in Mestastop Solutions.
As of 15 May 2024, investors collectively hold 27.8% equity in Mestastop Solutions.
Mestastop Solutions's ESOP pool stands at 8.8% of total equity as of 15 May 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links